In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


30 Rising Leaders

In Vivo's latest list of 30 people to watch across the biopharma, medtech and healthtech sectors

In Vivo’s 2023 Rising Leaders: Healthcare Innovators At The Top Of Their Game

The fourth annual listing of In Vivo’s ‘Rising Leaders’ includes entrepreneurs and innovators from across the world who represent the next wave of creativity in healthcare.

Leadership Business Strategies Diversity & Inclusion

In Vivo's 2023 Rising Leaders At A Glance

Top 30 leaders: see the list of industry influencers highlighted in the fourth edition of In Vivo's Rising Leaders series.

Rising Leaders Leadership StartUps and SMEs
2023 Rising Leaders

SpliceBio CEO: The Route From US Academic To Spanish Gene Tech Entrepreneur

From an early stage in his career, Miquel Vila-Perelló saw himself as a research academic. It was an ambition he duly fulfilled. Later, seeing the greater potential to bring benefit to human health by forming his own company, he co-founded SpliceBio, a Spain-based startup focusing on gene therapies for rare diseases.

Ophthalmic Business Strategies

Next-Gen ADCs: Araris CEO Highlights Potential In Linker Technology

In Vivo sat down with 2023 Rising Leader Philipp Spycher, CEO of Araris Biotech, to discuss trends in antibody-drug conjugate R&D, and how Araris hopes to disrupt today’s chemotherapy treatment paradigm with novel linker technology.

Rising Leaders Innovation

Exploring Alltrna’s Rare Disease Platform

Michelle Werner, CEO of Alltrna, sat down with In Vivo to discuss rare disease as an increasingly important area of study, innovation in the space and how the emerging biotech hopes to impact the treatment landscape.

Rare Diseases Rising Leaders

A Passion For Patient Care And De-Risking Disruptive Technologies

Biomedical engineering graduate Cécile Dupont has for the past 12 years helped healthcare technology businesses develop disruptive solutions that positively impact patients’ lives. The current chapter of her career opened in 2017 when she joined Sofinnova MD Start, the early-stage medtech incubator of VC investor Sofinnova Partners, where she is a partner.

Rising Leaders Innovation

AI Medical Technology: The Trials, Tribulations And Motivations Behind A Start-Up

Christoffer Ekström, one of In Vivo's 2023 Rising Leaders, spoke about the challenges a start-up founder faces, the importance of never giving up and how one should always learn from the past.

Medical Device Rising Leaders

It’s Time For A Billion-Dollar Women's Health Fund

Jessica Federer, former chief digital officer at Bayer, talks to In Vivo about making the jump into investing and why women’s health is a rich and deep market set for change.

Financing Women's Health

From Nokia To Thyroid Monitoring – Via The Digital Hearing Aid Industry

Medtech was not on Jesper Kimer’s radar when pioneering mobile phone company Nokia took him into its graduate program. A few career turns later, having fulfilled a desire to become an entrepreneur, his expertise and interests met in the middle when he co-founded thyroid disorder home monitoring start-up, HEI Therapeutics.

Rising Leaders Innovation

Manus Neurodynamica: Catching Up With A 2022 Rising Leader

2022 was a turbulent year for start-ups, especially in medtech. However, Rutger Zietsma has persisted, refocused and is ready for further success with his company, Manus Neurodynamica.

Rising Leaders Diagnostics

360 View Of Healthcare: Balancing Physician Training And Biotech Development

One of In Vivo’s 2023 Rising Leaders, Pheast Therapeutics’ chief development officer Amira Barkal, is also busy becoming a qualified physician. She is in the unusual position of leading an early-stage drug development program and being hands-on helping patients at the same time.

Rising Leaders Innovation

Being A Preferred Partner: Spero Therapeutics’ Plans For Growth

Erin Wenzel, director of alliance management at Spero Therapeutics, talks to In Vivo about working with a big pharma partner and Spero’s strategy for future growth.

Rising Leaders Business Strategies

Connecting The Dots Between Diversity, Empowerment And Business Growth

Urmi Prasad Richardson brings a wealth of science and business experience to diagnostics and life sciences multinational Thermo Fisher Scientific, where for the past two years she has been president of the group’s vast and varied EMEA business. The Indian-born, Germany-based executive has surmounted a range of challenges along the way and offers her story as inspiration for others.

Rising Leaders Leadership

Hexarad: Building A Professional Community Of Remote-Working Radiologists

British teleradiology provider Hexarad has shot from strength to strength in recent years, launching two different programs and opening up opportunities for its network of radiologists to continue supporting the National Health Service while working abroad. Company CEO Farzanah Rahman, one of In Vivo’s 2023 Rising Leaders, discussed Hexarad’s expansion, its values and the myth of the sole leader.

Rising Leaders Diagnostic Imaging
2022 Rising Leaders
2021 Rising Leaders
2020 Rising Leaders